Claudius, Birgitte
Novo Nordisk (Denmark)
3 papers on CoChat
Most cited papers
- Verified
Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial
on behalf of the SCALE study group, Blackman, A., Foster, G. D., Zammit, G., Rosenberg, R., Aronne, L., Wadden, T., Claudius, B., Jensen, C. B., & Mignot, E. (2016) · International Journal of Obesity
Obstructive Sleep Apnea ResearchPharmacology and Obesity Treatment
Cited by 583
- Verified
Early weight loss with liraglutide 3.0 mg predicts 1-year weight loss and is associated with improvements in clinical markers
Fujioka, K., O'Neil, P. M., Davies, M., Greenway, F., C.W. Lau, D., Claudius, B., Skjøth, T. V., Bjørn Jensen, C., & P.H. Wilding, J. (2016) · Obesity
Pharmacology and Obesity TreatmentDiabetes Treatment and Management
Cited by 131
- Verified
Liraglutide 3.0 mg for weight management: weight-loss dependent and independent effects
Bays, H., Pi-Sunyer, X., Hemmingsson, J. U., Claudius, B., Jensen, C. B., & Van Gaal, L. (2017) · Current Medical Research and Opinion
Pharmacology and Obesity TreatmentDiabetes Treatment and Management
Cited by 48
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free